Clinical Trial

Suzetrigine for Non-Mastectomy Breast Surgery

Enrolling by Invitation Phase 4
View on ClinicalTrials.gov →
Summary
This is a single-center clinical study to investigate the efficacy of a Food and Drug Administration-approved analgesic, suzetrigine, to treat pain following non-mastectomy breast surgery in concert with a single-injection paravertebral nerve block.
Protocol Amendment History 3 changes
critical Trial status changed: Not Yet Recruiting → Enrolling by Invitation 2026-04-30
notable Primary completion pushed: 2027-08-30 -> 2027-12-28 2026-04-30
minor Completion pushed: 2027-09-30 -> 2027-12-31 2026-04-30
Trial Details
NCT Number NCT07463430
Lead Sponsor University of California, San Diego
Collaborators: Vertex Pharmaceuticals Incorporated
Conditions Pain, Acute Postoperative, Breast Disease
Enrollment 120 participants
Start Date 2026-04-14
Primary Completion 2027-12-28 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-04-29